Shimadzu Corporation

Shimadzu Corporation, deeply rooted and headquartered in Kyoto, Japan, is a massive, highly respected global titan in the manufacturing of high-precision analytical and measuring instruments. Founded in 1875, Shimadzu proudly boasts a profound, century-long legacy of meticulous Japanese engineering and groundbreaking scientific innovation. This legacy was most notably highlighted on the global stage when their researcher, Koichi Tanaka, was awarded the Nobel Prize in Chemistry for his revolutionary advancements in mass spectrometry.

Operating as a colossal enterprise with over 14,600 employees and generating approximately $3.6 billion in annual revenue, Shimadzu provides an incredibly comprehensive, highly robust suite of laboratory equipment. This extensively includes advanced liquid and gas chromatographs (HPLC/GC), ultra-precise mass spectrometers, and highly sensitive spectrophotometers. These robust instruments are absolutely critical for rigorous pharmaceutical quality control, complex environmental testing, and advanced food safety analysis globally.

Beyond standard analytical chemistry, Shimadzu uniquely integrates highly advanced medical diagnostic imaging systems directly into its corporate portfolio, generating a significant portion of its revenue from specialized X-ray television (TV) systems and angiography equipment.

The company is currently heavily investing in revolutionary, cutting-edge technologies like advanced matrix-assisted laser desorption/ionization (MALDI) mass spec imaging. This technology drastically improves the ability to map complex biomarkers directly in biological tissues, bridging the gap between chemical analysis and clinical pathology. Driven by its core corporate philosophy of “Realizing Our Wishes for the Well-being of both Mankind and the Earth”, Shimadzu perfectly combines extreme, unwavering instrument reliability with highly advanced technological innovation.